Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg
EAU Podcasts8 Nov 2023

Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg

In this podcast, Dr. Neeraj Agarwal (US), presidential endowed chair of cancer research at the Huntsman Cancer Institute, University of Utah, shares the results of the LITESPARK-013 Phase 2 trial - "Safety and efficacy of two doses of belzutifan in patients with advanced renal cell carcinoma", that he presented at ESMO 2023. Firstly, Dr. Agarwal shares the rationale of the study, which compared belzutifan 200mg and 120mg doses in patients with advanced clear cell RCC that progressed on...

Episoder(212)

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
mikkels-paskenotter
foreldreradet
treningspodden
rss-strid-de-norske-borgerkrigene
jakt-og-fiskepodden
sinnsyn
rss-bisarr-historie
takk-og-lov-med-anine-kierulf
rss-kull
rss-sunn-okonomi
fryktlos
hverdagspsyken
tomprat-med-gunnar-tjomlid
level-up-med-anniken-binz
hagespiren-podcast
gravid-uke-for-uke
rss-kunsten-a-leve